西班牙全国登记分析:狼疮肾炎与抗磷脂综合征患者子痫前期风险升高
基于西班牙医院出院数据库2016至2022年1973249例产科住院的分析显示,系统性红斑狼疮患者子痫前期发生率为5.5%、伴严重标准子痫前期为2.1%,均高于对照的2.1%和0.6%;合并狼疮肾炎或抗磷脂综合征者风险进一步升高。校正分析显示系统性红斑狼疮、狼疮肾炎和抗磷脂综合征均与子痫前期及伴严重标准子痫前期独立相关。
要点
- 系统性红斑狼疮患者子痫前期5.5%、伴严重标准子痫前期2.1%,均高于对照的2.1%和0.6%。
- 狼疮肾炎合并抗磷脂综合征者子痫前期达22.7%、伴严重标准子痫前期达9.1%。
- 校正后狼疮肾炎与伴严重标准子痫前期相关(OR=2.45,95%CI 1.18-5.09)。
核心结论
- 系统性红斑狼疮患者子痫前期及伴严重标准子痫前期风险升高,有狼疮肾炎或抗磷脂综合征病史者进一步放大。
- 识别系统性红斑狼疮、抗磷脂综合征尤其是狼疮肾炎对精准风险分层和个体化管理以改善母婴结局至关重要。
研究设计与样本
- 基于西班牙医院出院数据库的分析,纳入2016至2022年间住院的孕妇。
- 在1973249例住院中,1787例患者有系统性红斑狼疮(9.1‰),其中13.2%有狼疮肾炎病史。
- 评估与子痫前期及伴严重标准子痫前期相关的因素,包括早发型子痫前期、重度子痫前期、子痫和HELLP综合征。
主要发现
- 系统性红斑狼疮患者子痫前期发生率为5.5%、伴严重标准子痫前期为2.1%,对照分别为2.1%和0.6%。
- 仅合并狼疮肾炎的系统性红斑狼疮患者子痫前期为10.3%、伴严重标准子痫前期为4.2%。
- 同时合并狼疮肾炎和抗磷脂综合征的系统性红斑狼疮患者子痫前期为22.7%、伴严重标准子痫前期为9.1%。
- 校正分析显示子痫前期与系统性红斑狼疮(OR=1.78,95%CI 1.39-2.28)、狼疮肾炎(OR=1.94,95%CI 1.18-3.19)、抗磷脂综合征(OR=1.53,95%CI 1.28-1.84)相关。
- 校正分析显示伴严重标准子痫前期与系统性红斑狼疮(OR=2.17,95%CI 1.47-3.22)、狼疮肾炎(OR=2.45,95%CI 1.18-5.09)、抗磷脂综合征(OR=1.91,95%CI 1.44-2.54)相关。
关键数值与推荐
- 在系统性红斑狼疮患者中,基线高血压(OR=4.27,95%CI 2.45-7.44)、狼疮肾炎(OR=2.06,95%CI 1.26-3.37)和抗磷脂综合征(OR=1.85,95%CI 1.03-3.32)与子痫前期相关。
- 在系统性红斑狼疮患者中,仅狼疮肾炎预测伴严重标准子痫前期(OR=2.88,95%CI 1.41-5.91)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evaluate the association of APS and SLE, focusing on LN, with risk of pre-eclampsia (PE) and PE with severity criteria (PESC). METHODS: Analysis of pregnant women admitted between 2016-2022, using data from the Spanish Hospital Discharge Database. Factors associated with PE and PESC, including early-onset PE, severe PE, eclampsia and HELLP syndrome were evaluated. RESULTS: Among 1 973 249 admissions, 1787 patients had SLE (9.1‰), with prior LN in 13.2%. SLE patients experienced higher PE (5.5% vs 2.1%) and PESC (2.1% vs 0.6%) rates; these rose further in SLE women with LN alone (PE: 10.3%, PESC: 4.2%) or with both LN and APS (PE: 22.7%, PESC: 9.1%) . Adjusted analyses showed PE and PESC were each associated with SLE (OR = 1.78, 95% CI 1.39-2.28; OR = 2.17, 95% CI 1.47-3.22), LN (OR = 1.94, 95% CI 1.18-3.19; OR = 2.45, 95% CI 1.18-5.09) and APS (OR = 1.53, 95% CI 1.28-1.84; OR = 1.91, 95% CI 1.44-2.54). Within SLE patients, baseline hypertension (OR = 4.27, 95% CI 2.45-7.44), LN (OR = 2.06, 95% CI 1.26-3.37) and APS (OR = 1.85, 95% CI 1.03-3.32) were linked to PE, while LN alone predicted PESC (OR = 2.88, 95% CI 1.41-5.91). CONCLUSION: The risk of PE and PESC that patients with SLE exhibit is further amplified in those with a history of LN or APS. Recognizing SLE, APS and especially LN is crucial for precise risk stratification and tailored management to improve maternal and fetal outcomes.
引用
- Martín-Portugués M, Esteban-Sampedro J, Mellor-Pita S, et al. Elevated pre-eclampsia risk in lupus nephritis and antiphospholipid syndrome: a nationwide Spanish registry analysis. Rheumatology (Oxford). 2026. PMID: 40971681. doi:10.1093/rheumatology/keaf484
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。